New service from J. Knipper debuts at PDMA Sharing Conference
Compliance with marketing restrictions—especially for pharma companies operating under corporate integrity agreements—is a constant source of concern for field sales and marketing teams. There are numerous approaches to maintaining compliance processes, but aligning these with customer relationship management (CRM) and multichannel marketing (MCM) programs is a challenge. Now, J. Knipper and Co. (Lakewood, NJ) hopes to reduce some of those challenges by offering a system and database that qualifies healthcare providers to receive drug samples, promotional materials and messages, and similar HCP interactions. J. Knipper is the largest sample-distribution company in the US, and has substantial business in fulfilling mail campaigns and similar marketing efforts for pharma clients.
The new service, AssureHCP, builds off Knipper’s existing status as one of a dozen or so licensees of AMA database, considered by many to be the most reliable source of master data on physician identities and licenses. But Knipper brings in other data sources, and is bidding eventually to become a master data management vendor in full, according to Mike Laferrera, president of the company. “AssureHCP is an extension of the compliant processes we already provide for sampling accountability, and now with our proprietary software we can offer these validation and certification processes with fewer ‘moving parts’ to pharma marketing managers.”
Depending on the drug, the marketing approach and the pharma company, communications between manufacturers and prescribers can be restricted to those with appropriate affiliations, DEA licenses, medical specialties and Medicare-service eligbility. Knipper provides this validated information via an online portal; it also qualifies prescribers by “categories of risk” by state and federal guidelines—said by Knipper to be an industry first. Data can be integrated into CRM programs down to individual program levels.
The new service debuted at the PDMA Sharing Conference, a gathering of industry sample-accountability managers, today.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.